Iron sucrose
- Generic Name
- Iron sucrose
- Brand Names
- Velphoro, Venofer
- Drug Type
- Small Molecule
- Chemical Formula
- C12H29Fe5Na2O23
- CAS Number
- 8047-67-4
- Unique Ingredient Identifier
- FZ7NYF5N8L
- Background
Iron sucrose (sucroferric oxyhydroxide or iron saccharate) is used as a source of iron in patients with iron deficiency anemia with chronic kidney disease (CKD), including those who are undergoing dialysis (hemodialysis or peritoneal) and those who do not require dialysis. Due to less side effects than iron dextran, iron sucrose is more preferred in chronic kidney disease patients.
- Indication
Iron sucrose is elemental iron as an injection. It replenishes body iron stores in patients with iron deficiency.
- Associated Conditions
- Hyperphosphataemia
Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
- First Posted Date
- 2008-07-23
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00721188
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Norristown, Pennsylvania, United States
Safety and Efficacy of Iron Sucrose in Children
- Conditions
- Chronic Kidney DiseaseAnemia
- Interventions
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 141
- Registration Number
- NCT00239642
- Locations
- 🇺🇸
Luitpold Pharmaceutials, Norristown, Pennsylvania, United States
Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
- Conditions
- Anemia
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 121
- Registration Number
- NCT00236938
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 182
- Registration Number
- NCT00236977
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Valley Forge, Pennsylvania, United States
Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure
- Conditions
- Chronic Heart FailureHeart DiseasesAnemia, Iron-Deficiency
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- National Heart and Lung Institute
- Target Recruit Count
- 42
- Registration Number
- NCT00125996
- Locations
- 🇬🇧
Wexham Park Hospital, Wexham Park, Slough, Berkshire, United Kingdom
🇵🇱4th Military Clinical Hospital, Weigla 5, Wroclaw, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.